Four years after Sanofi shelled out $125 million for global rights to Biond Biologic | The company is handing back the tumor ...
Net sales down 10.0% to €911.9 million, driven by lower volumes for Sanofi and the suspension of production at Brindisi, only ...
Operational resilience and strong increase in Free Cash Flow before financing in a challenging environment Net sales down 10.0% to €911.9 ...
Already billed as a potential blockbuster, Amgen and AstraZeneca’s Tezspire has turned in strong clinical data in chronic ...
Eggs are disappearing from store shelves due to shortages caused by the avian flu outbreak, but never fear — the eggs used to ...
California made a big bet on producing its own insulin. There’s no ‘date certain’ for delivery
California made a bold announcement that it would manufacture a state-branded, low-cost insulin. It still is not here.
18hon MSN
Why it matters: More than 3.5 million Californians have diabetes, and insulin is a life-saving part of their disease ...
Major pharmaceutical products and medicines have jumped in prices despite and executive order by President Bola Tinubu, ...
SBI Magnum Midcap Fund - Direct (G) 226.08 4,09,188 1.07 SBI Magnum Midcap Fund - Direct (IDCW) 226.08 4,09,188 1.07 Aditya Birla SL Frontline Equity Fund (G) 138.54 2,50,741 0.49 Aditya Birla SL ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback